SURVIVAL AND DESFERRIOXAMINE IN THALASSEMIA MAJOR

被引：207
|
作者：
MODELL, B
LETSKY, EA
FLYNN, DM
PETO, R
WEATHERALL, DJ
机构：
[1] HOSP SICK CHILDREN,LONDON WC1N 3JH,ENGLAND
[2] ROYAL FREE HOSP,LONDON NW3 2QG,ENGLAND
[3] RADCLIFFE INFIRM,NUFFIELD DEPT CLIN MED,CLIN TRIAL SERV UNIT,OXFORD OX2 6HE,ENGLAND
[4] UNIV OXFORD,JOHN RADCLIFFE HOSP,NUFFIELD DEPT CLIN MED,MRC,MOLEC HAEMATOL UNIT,OXFORD OX3 9DU,ENGLAND
来源：
BRITISH MEDICAL JOURNAL | 1982年 / 284卷 / 6322期
关键词：
D O I：
10.1136/bmj.284.6322.1081
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1081 / 1084
页数：4
相关论文
共 50 条
  • [21] Survival and disease complications in thalassemia major
    Borgna-Pignatti, C
    Rugolotto, S
    De Stefano, P
    Piga, A
    Di Gregorio, F
    Gamberini, MR
    Sabato, V
    Melevendi, C
    Cappellini, MD
    Verlato, G
    COOLEYS ANEMIA: SEVENTH SYMPOSIUM, 1998, 850 : 227 - 231
  • [22] Survival Comparability Between Thalassemia Major Versus Thalassemia Intermedia
    Vitrano, Angela
    Calvaruso, Giuseppina
    Lai, Eliana
    Colletta, Grazia
    Quota, Alessandra
    Gerardi, Calogera
    Rigoli, Luciana Concetta
    Cuccia, Liana
    Gagliardotto, Francesco
    Filosa, Aldo
    Caruso, Vincenzo
    Argento, Crocetta
    Campisi, Saveria
    Rizzo, Michele
    Fidone, Carmelo
    Rigano, Paolo
    Sacco, Massimiliano
    Pepe, Alessia
    Di Maggio, Rosario
    Pitrolo, Lorella
    Maggio, Aurelio
    BLOOD, 2015, 126 (23)
  • [23] HEARING-LOSS ATTRIBUTED TO DESFERRIOXAMINE IN PATIENTS WITH BETA-THALASSEMIA MAJOR
    BARRATT, PS
    TOOGOOD, IRG
    MEDICAL JOURNAL OF AUSTRALIA, 1987, 147 (04) : 177 - 179
  • [24] EFFECTIVE IRON EXCRETION USING CONTINUOUS SUBCUTANEOUS DESFERRIOXAMINE INFUSIONS IN THALASSEMIA-MAJOR
    KONIG, R
    BECK, W
    JENTSCH, F
    SCHROTER, W
    TILLMANN, W
    MONATSSCHRIFT KINDERHEILKUNDE, 1982, 130 (08) : 685 - 685
  • [25] HEARING-LOSS ATTRIBUTED TO DESFERRIOXAMINE IN PATIENTS WITH BETA-THALASSEMIA MAJOR - REPLY
    TOOGOOD, IRG
    BARRATT, PS
    MEDICAL JOURNAL OF AUSTRALIA, 1988, 148 (12) : 662 - 663
  • [26] Effect of iron chelator desferrioxamine on serum zinc levels in patients with beta thalassemia major
    Sultan, Sadia
    Irfan, Syed Mohammed
    Kakar, Jamaluddin
    Zeeshan, Rozina
    MALAYSIAN JOURNAL OF PATHOLOGY, 2015, 37 (01) : 35 - 38
  • [27] Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload
    S. Daar
    A. V. Pathare
    Annals of Hematology, 2006, 85 : 315 - 319
  • [28] No progression of liver fibrosis in thalassemia major during deferiprone or desferrioxamine iron chelation.
    Piga, A
    Facello, S
    Gaglioti, C
    Pucci, A
    Pietribiasi, F
    Zimmermann, A
    BLOOD, 1998, 92 (10) : 21B - 21B
  • [29] Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload
    Daar, S.
    Pathare, A. V.
    ANNALS OF HEMATOLOGY, 2006, 85 (05) : 315 - 319
  • [30] IMPROVED SURVIVAL IN BETA-THALASSEMIA MAJOR
    GIARDINA, PJ
    EHLERS, K
    LESSER, M
    CONNELLY, M
    WEINSTEIN, D
    JEW, E
    HILGARTNER, MW
    PEDIATRIC RESEARCH, 1987, 21 (04) : A299 - A299
12345